DermTech Revenue
What is the Revenue of DermTech?
The Revenue of DermTech, Inc. is $15.664M
What is the definition of Revenue?
Revenue is the income that a business has from its normal business activities, usually from the sale of goods and services to customers.
ttm (trailing twelve months)
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenue of companies in the Health Care sector on NASDAQ compared to DermTech
What does DermTech do?
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
Companies with revenue similar to DermTech
- Delecta has Revenue of AUD$15.622M
- Goldgroup Mining has Revenue of $15.630M
- Nicholas has Revenue of $15.643M
- Citadel Realty and Developers has Revenue of ₨15.643M
- Atlantic Sapphire ASA has Revenue of $15.651M
- Chinese Food and Beverage has Revenue of HKD$15.655M
- DermTech has Revenue of $15.664M
- Touch Ventures Ltd has Revenue of AUD$15.692M
- Fronsac Real Estate Investment Trust has Revenue of CAD$15.706M
- Vidler Water Resources Inc has Revenue of $15.721M
- Orbital has Revenue of AUD$15.721M
- Martello Technologies has Revenue of CAD$15.770M
- Eiger BioPharmaceuticals Inc has Revenue of $15.773M